Testing if sesame allergy can become long-lasting after therapy
Part of Immune system & allergy clinical trials.
This study checks if children who already reached a maintenance dose of sesame protein in a previous immunotherapy can stop treatment and stay unresponsive to sesame. It aims to see if the protection lasts over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed sesame allergy.
- You must have already finished the first part of this study and reached the maintenance dose of 300 mg sesame protein.
- You or your caregiver must agree to participate and cooperate with the study team.
- You cannot have severe asthma or poorly controlled mild/moderate asthma.
- You cannot have had certain steroid treatments or use specific medications like beta-blockers or ACE inhibitors.
- You cannot be pregnant or have certain chronic diseases like heart disease, epilepsy, or diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether people who already completed cashew oral immunotherapy can stop eating cashew protein and still be protected from allergic reactions. It helps researchers understand if the treatment leads to lasting tolerance.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This study tests a treatment that gradually exposes children to small amounts of peanut and certain tree nuts to reduce their allergy. It aims to help children safely tolerate multiple nuts at once.
This study watches how milk and egg allergies change naturally over time or after oral immunotherapy (OIT) in children. It helps researchers understand how the immune system adapts, aiming to improve treatment for food allergies.
This study compares two ways of doing oral immunotherapy (gradually eating more of the allergen) for children with cow's milk or hen's egg allergy. It aims to find which method is safer and works better.
This study tests an oral (mouth) sesame treatment designed to help the body stay “unresponsive” to sesame after treatment. If you previously took part in the earlier sesame study, this trial may help you see whether a sustained tolerance can be achieved and maintained.
Hear when a new Food Allergy in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.